iPS Cell-based Research Project on Hepatic Toxicity and Metabolism

஻࿪‫ܖ‬๕ܿ੅‫ٳ‬อξΣΛΠ
‫܈‬Ήη΃σρͼήρςȜίυΐͿ·Π
教授(兼任)
客員教授
特任教授
特任助教(常勤)
辻川 和丈
寺下 善一
目黒 寛治
神宮司健太郎
Cancer chemical library project
Kazutake TSUJIKAWA 06-6879-8190
Zen-ichi TERASHITA 06-6879-4412
Specially Appointed Professor Kenji MEGURO
06-6879-4412
Specially Appointed Assistant Professor Kentaro JINGUSHI 06-6879-8192
[email protected]
[email protected]
[email protected]
[email protected]
Professor
Visiting Professor
教 授 辻川 和丈
ȁ՛଻૧୆໤ȶ‫܈‬ȷ͉࡛ह̦࣭͈ͩঘཌࡔ֦͈ΠΛίͬ
୸͛ͥ৖̳ۛ́ȃ̭͈̽̀͢‫ͅ܈‬చ̳ͥခ࢘̈́হၷ࿪͈
஻ୋࡄ‫͂ݪ‬Ȃ̷͈ࡄ‫ͅܢ்ͬض଼ݪ‬ႉ઄͒එ̫̭̦ͥ͂
࿪‫͈ݪࡄڠ‬ਹါ̈́ঀྵ̞̳͂̈́̽̀͘ȃ̷͈̹͉͛ͅȂ
‫܈‬ळ༾͈௩૓Ȃ૫੕Ȇഢ֊̯͉ͣͅࢯ‫܈‬सఛ଻ෝ‫ͬࢹܥ‬
֒ഥঊȂΗϋΩ·ৗτασٜ́ྶ̱Ȃ̷͈ͦͣอ࡛͞‫ܥ‬
ෝͬଷࢄ̧́ͥ੅ͬ༎͙੄̳ࡄ‫̦ݪ‬୨བ̯̞̳ͦ̀͘ȃ
ུίυΐͿ·Π͉́໲໐‫ڠش‬જड୶౤ࡄ‫ܖݪ‬๕মުȶ‫ا‬
ࣣ໤ρͼήρςȜͬ‫ڰ‬ဥ̱̹஻࿪൝ड୶౤ࡄ‫ݪ‬Ȇ‫ܖ֗ޗ‬
๕͈ା๵ȷ̤̞̀ͅȂႉ઄͈͂ࡄ‫ފݪ‬ႁͤ͢ͅ‫܈‬ႉ઄࠿
ఘͬဥ̞̀‫͈܈‬αȜσͬญ̦̱Ȃহၷດഎ͂̈́ͥ໦ঊͬ
ౝ̱̞̳॑̀͘ȃ̷̹͈͘ດഎ໦ঊ͈‫ܥ‬ෝٜͬྶ̱Ȃ̷
͈‫ܥ‬ෝͬ‫ࣣا‬໤ͬဥ̞̀ଷࢄ̳̭ͥ͂ͬ࿒ঐ̱̹ड୶౤
ࡄ‫̳̞̀͛͘ૺͬݪ‬ȃ̷ͦͤ͢ͅ‫͈܈‬໦ঊດഎহၷ࿪͈
ْ‫ܢ‬എ֓࿪຦ȪŧŪųŴŵĮŪůĮŤŭŢŴŴȫȂ‫ܡ‬ం࿪ͅచ̱̀ྶ‫̈́ږ‬
࿹պ଻ͬ঵̾֓࿪຦ȪţŦŴŵĮŪůĮŤŭŢŴŴȫͬ஻ୋ̱Ȃႉ઄ͅ
එ̫̭ͥ͂ͬ࿒ঐ̱̳͘ȃ
䛜䜣⣽⬊
ᶆⓗศᏊ䛾Ỵᐃ
䝬䜲䜽䝻䜰䝺䜲
ゎᯒ
ABH3䛾
X⥺⤖ᬗ
ᵓ㐀ゎᯒ
䜿䝭䜹䝹䝷䜲䝤䝷䝸䞊䜢
⏝䛔䛯invitro,invivoホ౯
䛜䜣䛾ศᏊᶆⓗ἞⒪⸆䛾๰〇
ड߃͈৽ါა໲
1. Nakao S. et al., Design and synthesis of prostate cancer antigen-1 (PCA-1/ALKBH3) inhibitors as anti-prostate cancer drugs. Bioorg Med Chem Lett., 24, 1071-4, 14
஻࿪‫ܖ‬๕ܿ੅‫ٳ‬อξΣΛΠ
ŪőŔ ۴ඉ଻Ȇయ৫ίυΐͿ·Π
iPS Cell-based Research Project on
Hepatic Toxicity and Metabolism
教 授(兼任) 水口 裕之 Professor
Hiroyuki MIZUGUCHI 06-6879-8185
特任助教(常勤) 酒井 英子 Specially Appointed Assistant Professor Eiko SAKAI
06-6879-8187
[email protected]
[email protected]
教 授 水口 裕之
ȁΪΠ ŪőŔ ळ༾͉۴௫൝͈̜ͣͥ͠ழ૕Ȇळ༾ͅ໦‫̳ا‬
̭̥ͥ͂ͣȂ࿪໤͈ඉ଻ບ‫͞ࠏث‬ठ୆֓ၷ൝͈͒؊ဥ̦
‫ܢ‬ఞ̯̞ͦ̀ͥȃ̱̥̱̦̈́ͣȂਲြ͈‫֦଻ס‬ঊȪ΍ͼ
Π΃ͼϋ൝ȫͥ͢ͅ໦‫ا‬ည൵༹͉́Ȃ۴ळ༾͈͒໦‫࢘ا‬
ၚ̦ޭ͛̀೩̞̭̦͂‫ه‬ఴ̞͂̈́̽̀ͥȃِș͉Ȃ۴௫
͈อ୆ͅਹါ̈́֒ഥঊͬ໦‫͈ا‬ഐ୨̈́শ‫ͅܢ‬൵ව̳̭ͥ
͂ͤ͢ͅȂ۴ळ༾͈͒໦‫ͬا‬๲࿬എͅ௯ૺ̵̯Ȃ੝య෽
ူΪΠ۴ळ༾ͅ຀ഌ̳ͥτασ͈࿪໤య৫ࣖள͈֒ഥঊ
อ࡛τασͬা̳۴ळ༾͈ैୋ଼̱̹ࢗͅȃ
ȁِșུ͉۴ळ༾ͬȂ૧࿪‫ٳ‬อࡄ‫͈́ݪ‬၌ဥ̦‫ܢ‬ఞ̯ͦ
ͥ ŪůġŷŪŵųŰ ඉ଻ບ‫͞ࠏث‬۴య৫Ȃࣖளည൵ບ‫ͅࠏث‬၌ဥ
̳̭ͥ͂ͬ࿒എͅȂ̷͈‫ܖ‬๕ܿ੅‫ٳ‬อ࣐̞ͬ̽̀ͥȃ̯
ͣͅȂ۴‫ͼ;׶‬σΑࡄ‫͈͒ݪ‬؊ဥ͞Ȃ۴ळ༾໦‫۾ͅا‬ဓ
̳ͥ֒ഥঊ͈‫ܥ‬ෝٜଢ଼Ȃᦙϸळ༾͞઀ಸષ๧ळ༾൝͈͒
໦‫ا‬ည൵ܿ੅‫ٳ‬อ൝͈ࡄ‫̞࣐ͥ̀̽ͬݪ‬ȃ
ȁոષུ͈̠͢ͅ໦࿤͉́Ȃ໦ঊ୆໤‫ڠ‬໦࿤͈͂Ⴒࠈ͈
͂͜ȂŪőŔ ळ༾ܿ੅ͬߐঀ̱̹஻࿪ࡄ‫̤࣐ͤ̀̽ͬݪ‬Ȃ
ུ໦࿤ͬ୶൵̧́ͥ૽ऺ଼͈࣐̞֗ͬ̽̀ͥȃ
ࡄ‫هݪ‬ఴ
1)ヒト iPS 細胞から肝臓細胞への高効率分化誘導法の開発
2)ヒト iPS 細胞由来分化誘導肝細胞を用いた毒性評価・肝代
謝評価・薬効評価系の開発
3)ヒト iPS 細胞から膵臓細胞、小腸細胞等への高効率分化誘
導法の開発と創薬応用に関する研究
ड߃͈৽ါა໲
1. Nagamoto Y. et al., Efficient engraftment of human iPS cell-derived hepatocyte-like cells in uPA/SCID mice by overexpression of FNK, a Bcl-xL
mutant gene. Cell Transplantation, in press.
2. Watanabe H. et al., HHEX promotes hepatic-lineage specification through the negative regulation of eomesodermin. PLoS One, 9, e90791 (2014)
3. Takayama K. et al., &&$$7HQKDQFHUELQGLQJSURWHLQPHGLDWHGUHJXODWLRQRI7*)ȕUHFHSWRUH[SUHVVLRQGHWHUPLQHWKHKHSDWREODVWIDWHGHFLVLRQ
Development, 141, 91-100 (2014)
4. Takayama K. et al., Long-term self-renewal of human ES/iPS-derived hepatoblast-like cells on human Laminin 111-coated dishes. Stem Cell Rep.,
1,322-335 (2013)
5. Takayama K. et al., 3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing. Biomaterials, 34, 1781-1789 (2013)
7DND\DPD.HWDO*HQHUDWLRQRIPHWDEROLFDOO\IXQFWLRQLQJKHSDWRF\WHVIURPKXPDQSOXULSRWHQWVWHPFHOOVE\)2;$DQG+1)ĮWUDQVGXFWLRQ J. Hepatol., 57, 628-636 (2012)
஻࿪‫ܖ‬๕ܿ੅‫ٳ‬อξΣΛΠ
ŪőŔ ෞ૰ࠐඉ଻ίυΐͿ·Π
教授(兼任) 橋本 均
特任准教授 中澤 敬信
特任助教 永安 一樹
Professor
Specifically Appointed Associate Professor
Specifically Appointed Assistant Professor
iPS Cell-based Research Project on Brain
Neuropharmacology and Toxicology
Hitoshi HASHIMOTO
06-6879-8180
Takanobu NAKAZAWA 06-6879-8182
Kazuki NAGAYASU
06-6879-8183
Fax 06-6879-8184
[email protected]
[email protected]
[email protected]
教 授 橋本 均
ȁΪΠ ŪőŔ ळ༾͈
ै ୋ ܿ ੅ ͬ ဥ ̞Ȃ
ۛ৪͂࠲ુ৪͈
ŪőŔ ळ༾̷̸ͬͦ
ͦෞ૰ࠐळ༾ͅ໦
‫̵̯̀ا‬Ȃอో͞
૰ࠐ‫ܥ‬ෝͬ๤‫̳ڛ‬
ͥ ̭ ͂ ͅ ͢ ̽ ̀Ȃ
ۛ৪͈ෞ̦͈̓͢
̠̈́։ુͬ঵̽̀
̞̥ٜͥͬྶ̳ͥ
௷̦̥ͤͬං̹̞
ఉෝ଻ۚळ༾
ȪņŔȆŪőŔȫ
̥͈ͣΓυΠΣϋ૰ࠐळ༾͈໦‫͂ا‬੗‫ا‬
͂ ࣉ ̢ ̀ ̞ ͘ ̳ȃ
༹̭͈̠༷̈́̽̀͢͢ͅȂୈ૰৖͈ۛอછࡔ֦͈൳೰͞
হၷ࿪͈ດഎ໦ঊ͈ౝ॑ͬ࿒ঐ̱̳͘ȃ
ȁୈ૰৖͈ۛພ֦̱͂̀Ȃ႕̢͊ఉ̩͈֒ഥ֦ঊ۪͂‫ޏ‬
ါ֦̦ໝॠͅ௖ࡽैဥ̱̀อછ̳ͥ‫ب‬୰̈́̓Ȃఉତ͈ພ
֦‫ب‬୰̦೹া̯̞̳̦ͦ̀͘Ȃ৘બ̯̹͈͉̩ͦ̈́͜Ȃ
̷͈໦ঊι΃ΣΒθ͉ྚ̺͕͂ͭ̓ະྶ̳́ȃུίυΐͿ
·Π͉́૽ࢥఉෝ଻ۚȪŪőŔȫळ༾̈́̓ͬဥ̞̀Ȃո‫͈ئ‬
ࡄ‫ͤ৾ͅݪ‬ழ̞̳ͭ́͘ȃ
ˍȫఉෝ଻ۚळ༾̥͈ͣΓυΠΣϋ૰ࠐ͈͒໦‫͂ࢹܥا‬
̷͈ພఠഎփ͈ٜ݅ྶ
ȁΓυΠΣϋͬ‫͚܄‬κΦͺηϋయ৫͂ୈ૰৖͈ۛ͂‫۾‬Ⴒ଻̦
ঐഊ̯̤ͦ̀ͤȂΓυΠΣϋ૰ࠐ͈‫ܥ‬ෝٜଢ଼͉ਹါ̈́‫ه‬ఴ́
̳ȃίυΐͿ·ΠςȜΘȜ͈ͣࡄ‫ݪ‬৒Ȫ૰ࠐ࿪ၑ‫ڠ‬໦࿤ȫ́
͉̭ͦ́͘ͅȂζ;Α ņŔ ळ༾̥ͣȂŪůġŷŪŵųŰ ́ΓυΠΣϋ૰
ࠐळ༾ͬ໦‫̵̯ͥا‬ΏΑΞθ͈ࢹಃͬদ͙ȂडਞഎͅˍΑΞΛ
ί̥ͣ̈́ͥ۰༒̈́ίυΠ΋σ̵଼଼̱̯̭̱͂̀ۖͥ͂ࢗͅ
̱̹͘ȃ࡛हȂ̭ͦͬဥ̞̀ΓυΠΣϋ૰ࠐ͈໦‫ا‬ည൵͈̱
̩͙ͅ‫̳̞̀͛͘ૺͬݪࡄ̳ͥ۾‬ȃ‫ͅܡ‬ΓυΠΣϋ૰ࠐळ༾
ͅඅ։എͅอ࡛̳ͥ ŮŪŤųŰœŏł ͬ൳೰଼̳̭̱ͥ͂ࢗ̀͜ͅ
̤ͤȂ࡛ह̷͈‫ܥ‬ෝ͞ພఠഎ̈́࿨‫̞̀͛ૺͬݪࡄ̞̀̾ͅڬ‬
̳͘Ȫ଎४ચȫ
ȃ̹͘Ȃζ;Α ņŔ ळ༾́ං̹ͣͦ౶ࡉͬΪΠ
ŪőŔ ळ༾ͅ؊ဥ̱ȂŪőŔ ळ༾̥ͣΓυΠΣϋ૰ࠐͬࣞ੗ഽͅ໦
‫̵̯ͥا‬ΏΑΞθ͈‫ٳ‬อͬদ͙̞̳̀͘ȃ
ˎȫୈ૰৖ۛۛ৪͈ ŪőŔ ळ༾ͬဥ̞̹໦ঊພఠࡄ‫ݪ‬
ࡄ‫هݪ‬ఴ
1)多能性幹細胞からのセロトニン神経への分化機構とその病
態的意義の解明
2)精神疾患患者の iPS 細胞を用いた分子病態研究
ड߃͈৽ါა໲
1.
2.
3.
4.
Inoue T, et al. LMTK3 deficiency causes pronounced locomotor hyperactivity and impairs endocytic trafficking. J Neurosci. 2014; 34:5927-37.
Hoshina N, et al. Prococadherin 17 regulates presynaptic assembly in topographic corticobasal ganglia circuits. Neuron 2013; 78:839-54.
Ohi K, et al. The p250GAP gene is associated with risk for schizophrenia and schizotypal personality trait. PLoS ONE 2012; 7:e35696.
Shimada T, et al. A simplified method to generate serotonergic neurons from mouse embryonic stem and induced pluripotent stem cells. J Neurochem. 2012; 122:81-93.
஻࿪‫ܖ‬๕ܿ੅‫ٳ‬อξΣΛΠ
ŪőŔ ૤ࠬ‫ۯ‬Ȇࠬ‫ס‬ඉ଻ίυΐͿ·Π
iPS Cell-based Research Project on
Cardiovascular Toxicology
教授(兼任) 土井 健史 Professor
Takefumi DOI 06-6879-8158
特任講師(常勤) 石本 憲司 Specially Appointed Associate Professor Kenji ISHIMOTO 06-6879-8166
特任助教(常勤) 今西悠基子 Specially Appointed Assistant Professor Yukiko IMANISHI 06-6879-3153
特任講師 石本憲司
[email protected]
[email protected]
[email protected]
特任助教 今西悠基子
ȁ֓‫ૺ͈੅ܿڠ‬༜͜ͅ‫̴ͣͩ۾‬Ȃ੏۪‫ܕ‬৖͉̤ۛࣽ̈́୶
ૺ੨࣭͈৽ါঘ֦͈̳֚̾́ȃহၷ࿪͈ଇ௸̈́‫ٳ‬อ̦བ
̞̳̦ͦ̀͘͘Ȃਲြ༹͈༷͉́հ஠଻̤͍͢ඉ଻ບ‫ث‬
́ཛྷఱ̈́΋ΑΠ͂শ‫̥̥̦ͤۼ‬Ȃ‫ٳ‬อષ͈ၙ௸౲‫̽̈́͂ٴ‬
̞͈̦࡛̀ͥે̳́ȃ
জ̹̻͈ࡄ‫ݪ‬৒͉́ȂུίυΓᾺ̤̞ͅඅͅఉఱ̈́শ
‫ۼ‬ȂႻႁȂ΋ΑΠͬါ̳ͥ൲໤৘ࡑͬȂŪőŔ ဇြ໦‫ا‬ळ
༾̥ͣैୋ̱̹ழ૕ఘ́యఢ̳̭ͥ͂ͬ࿒എ̱͂̀ࡄ‫ݪ‬
ͬই̱̹͛͘ȃߓఘഎ͉ͅȂ‫ڐ‬ಫ߿૤޼છ͈̈́̓֒ഥഎ
ள֦ͬခ̳ͥ੏۪‫ܕ‬৖ۛͬΗȜΊΛΠ̱͂Ȃ
Ȫˍȫ࠲ુ৪
̤͍ۛ͢৪̥ͣ ŪőŔ ळ༾ͬैୋȂ
Ȫˎȫ૤޼ळ༾͒໦‫ا‬ည
൵Ȃ
Ȫˏȫࢥ‫ڠ‬എ਀༹ͬဥ̞ Ĵ ষࡓ͈ழ૕ఘͬैୋȂ
Ȫːȫ
‫ࣣا‬໤ρͼήρςȜ̥ͣ࢓༞࿪सഞ‫ح‬Ȃ
Ȫˑȫ૤޼အழ૕
ఘ͈࿪सͅచ̳ͥ؊൞ບ‫ͬث‬ঔ࣐̳ͥထ೰̳́ȃུࡄ‫ݪ‬
ͤ͢ͅ૧̹̈́࿪໤ບ‫ࠏث‬ΏΑΞθ͈ࢹಃ̦ࢹಃ̯ͦͦ͊Ȃ
஻࿪ίυΓΑ͈ࠠഎ̈́࢘ၚ‫̩̥ࣺ̈́́ͤ͊ͥ͛ࡉ̦ا‬Ȃ
࿪स͈ͤ͢ႉ઄ͅ߃̞࿪໤൲ఠͬບ‫ܢ̧̦̭͂ͥ́ث‬ఞ
̯̳ͦ͘ȃ̯ͣͅ൲໤৘ࡑၾ͈ఱ໙̈́ॉࡘ̦‫خ‬ෝ͂̈́ͤȂ
ႃၑഎ͜ͅབ̱̞͂͘ࣉ̢̤̳̀ͤ͘ȃ
ུίυΐͿ·Π͉໹଼ ijĶ ාഽͤ͢‫ٳ‬ই̱Ȃႉ઄؊ဥͬ
ુͅැ൮ͅ౾̞̀ࡄ‫ͤ৾ͅݪ‬ழ̞̳ͭ́͘ȃ
଎ġŪőŔ ဇြ૤޼ळ༾ȃζ;Α ŪőŔ ळ༾̥ͣ૤޼ळ༾ͅ໦
‫ا‬ည൵̱Ȃ྾‫ע‬அ૗Ȫષ଎ȫ̤͍͢ œŕĮőńœ ༹́ບ‫̱ث‬
̹̭͂ͧȂ૤޼අ։എഢৢ֦ঊ̜́ͥ ňłŕłĵ ̤͍͢
ŏŬŹijįĶȂਓੀ‫۾‬ႲΗϋΩ·̜́ͥϷĮŢŤŵŪůŪůȂťŦŴŮŪů ൝
͈อ࡛ͬ෇̹͛ȃ̹͘ ŪőŔ ळ༾ैୋͅष̱൵ව̱̹֒ഥ
ঊȪŐŤŵĵĭġŔŰŹijĭġŤĮŎźŤĭġŌŭŧĵȫ͈ อ ࡛ ͉ ෇ ͛ ̈́ ̥ ̽ ̹
ȃ
ȪŚŶġŕįġńŪųŤġŋġijıIJĴĭġŎŪŬŪġŌįġŔŵŦŮġńŦŭŭŴġŕųŢůŴŭġŎŦťġijıIJijȫ
஻࿪‫ܖ‬๕ܿ੅‫ٳ‬อξΣΛΠ
ŪőŔ ෞ૰ࠐඉ଻ίυΐͿ·Π
教授(兼任) 橋本 均
特任准教授 中澤 敬信
特任助教 永安 一樹
Professor
Specifically Appointed Associate Professor
Specifically Appointed Assistant Professor
iPS Cell-based Research Project on Brain
Neuropharmacology and Toxicology
Hitoshi HASHIMOTO
06-6879-8180
Takanobu NAKAZAWA 06-6879-8182
Kazuki NAGAYASU
06-6879-8183
Fax 06-6879-8184
[email protected]
[email protected]
[email protected]
教 授 橋本 均
ȁΪΠ ŪőŔ ळ༾͈
ै ୋ ܿ ੅ ͬ ဥ ̞Ȃ
ۛ৪͂࠲ુ৪͈
ŪőŔ ळ༾̷̸ͬͦ
ͦෞ૰ࠐळ༾ͅ໦
‫̵̯̀ا‬Ȃอో͞
૰ࠐ‫ܥ‬ෝͬ๤‫̳ڛ‬
ͥ ̭ ͂ ͅ ͢ ̽ ̀Ȃ
ۛ৪͈ෞ̦͈̓͢
̠̈́։ુͬ঵̽̀
̞̥ٜͥͬྶ̳ͥ
௷̦̥ͤͬං̹̞
ఉෝ଻ۚळ༾
ȪņŔȆŪőŔȫ
̥͈ͣΓυΠΣϋ૰ࠐळ༾͈໦‫͂ا‬੗‫ا‬
͂ ࣉ ̢ ̀ ̞ ͘ ̳ȃ
༹̭͈̠༷̈́̽̀͢͢ͅȂୈ૰৖͈ۛอછࡔ֦͈൳೰͞
হၷ࿪͈ດഎ໦ঊ͈ౝ॑ͬ࿒ঐ̱̳͘ȃ
ȁୈ૰৖͈ۛພ֦̱͂̀Ȃ႕̢͊ఉ̩͈֒ഥ֦ঊ۪͂‫ޏ‬
ါ֦̦ໝॠͅ௖ࡽैဥ̱̀อછ̳ͥ‫ب‬୰̈́̓Ȃఉତ͈ພ
֦‫ب‬୰̦೹া̯̞̳̦ͦ̀͘Ȃ৘બ̯̹͈͉̩ͦ̈́͜Ȃ
̷͈໦ঊι΃ΣΒθ͉ྚ̺͕͂ͭ̓ະྶ̳́ȃུίυΐͿ
·Π͉́૽ࢥఉෝ଻ۚȪŪőŔȫळ༾̈́̓ͬဥ̞̀Ȃո‫͈ئ‬
ࡄ‫ͤ৾ͅݪ‬ழ̞̳ͭ́͘ȃ
ˍȫఉෝ଻ۚळ༾̥͈ͣΓυΠΣϋ૰ࠐ͈͒໦‫͂ࢹܥا‬
̷͈ພఠഎփ͈ٜ݅ྶ
ȁΓυΠΣϋͬ‫͚܄‬κΦͺηϋయ৫͂ୈ૰৖͈ۛ͂‫۾‬Ⴒ଻̦
ঐഊ̯̤ͦ̀ͤȂΓυΠΣϋ૰ࠐ͈‫ܥ‬ෝٜଢ଼͉ਹါ̈́‫ه‬ఴ́
̳ȃίυΐͿ·ΠςȜΘȜ͈ͣࡄ‫ݪ‬৒Ȫ૰ࠐ࿪ၑ‫ڠ‬໦࿤ȫ́
͉̭ͦ́͘ͅȂζ;Α ņŔ ळ༾̥ͣȂŪůġŷŪŵųŰ ́ΓυΠΣϋ૰
ࠐळ༾ͬ໦‫̵̯ͥا‬ΏΑΞθ͈ࢹಃͬদ͙ȂडਞഎͅˍΑΞΛ
ί̥ͣ̈́ͥ۰༒̈́ίυΠ΋σ̵଼଼̱̯̭̱͂̀ۖͥ͂ࢗͅ
̱̹͘ȃ࡛हȂ̭ͦͬဥ̞̀ΓυΠΣϋ૰ࠐ͈໦‫ا‬ည൵͈̱
̩͙ͅ‫̳̞̀͛͘ૺͬݪࡄ̳ͥ۾‬ȃ‫ͅܡ‬ΓυΠΣϋ૰ࠐळ༾
ͅඅ։എͅอ࡛̳ͥ ŮŪŤųŰœŏł ͬ൳೰଼̳̭̱ͥ͂ࢗ̀͜ͅ
̤ͤȂ࡛ह̷͈‫ܥ‬ෝ͞ພఠഎ̈́࿨‫̞̀͛ૺͬݪࡄ̞̀̾ͅڬ‬
̳͘Ȫ଎४ચȫ
ȃ̹͘Ȃζ;Α ņŔ ळ༾́ං̹ͣͦ౶ࡉͬΪΠ
ŪőŔ ळ༾ͅ؊ဥ̱ȂŪőŔ ळ༾̥ͣΓυΠΣϋ૰ࠐͬࣞ੗ഽͅ໦
‫̵̯ͥا‬ΏΑΞθ͈‫ٳ‬อͬদ͙̞̳̀͘ȃ
ˎȫୈ૰৖ۛۛ৪͈ ŪőŔ ळ༾ͬဥ̞̹໦ঊພఠࡄ‫ݪ‬
ࡄ‫هݪ‬ఴ
1)多能性幹細胞からのセロトニン神経への分化機構とその病
態的意義の解明
2)精神疾患患者の iPS 細胞を用いた分子病態研究
ड߃͈৽ါა໲
1.
2.
3.
4.
Inoue T, et al. LMTK3 deficiency causes pronounced locomotor hyperactivity and impairs endocytic trafficking. J Neurosci. 2014; 34:5927-37.
Hoshina N, et al. Prococadherin 17 regulates presynaptic assembly in topographic corticobasal ganglia circuits. Neuron 2013; 78:839-54.
Ohi K, et al. The p250GAP gene is associated with risk for schizophrenia and schizotypal personality trait. PLoS ONE 2012; 7:e35696.
Shimada T, et al. A simplified method to generate serotonergic neurons from mouse embryonic stem and induced pluripotent stem cells. J Neurochem. 2012; 122:81-93.
஻࿪‫ܖ‬๕ܿ੅‫ٳ‬อξΣΛΠ
ŪőŔ ૤ࠬ‫ۯ‬Ȇࠬ‫ס‬ඉ଻ίυΐͿ·Π
iPS Cell-based Research Project on
Cardiovascular Toxicology
教授(兼任) 土井 健史 Professor
Takefumi DOI 06-6879-8158
特任講師(常勤) 石本 憲司 Specially Appointed Associate Professor Kenji ISHIMOTO 06-6879-8166
特任助教(常勤) 今西悠基子 Specially Appointed Assistant Professor Yukiko IMANISHI 06-6879-3153
特任講師 石本憲司
[email protected]
[email protected]
[email protected]
特任助教 今西悠基子
ȁ֓‫ૺ͈੅ܿڠ‬༜͜ͅ‫̴ͣͩ۾‬Ȃ੏۪‫ܕ‬৖͉̤ۛࣽ̈́୶
ૺ੨࣭͈৽ါঘ֦͈̳֚̾́ȃহၷ࿪͈ଇ௸̈́‫ٳ‬อ̦བ
̞̳̦ͦ̀͘͘Ȃਲြ༹͈༷͉́հ஠଻̤͍͢ඉ଻ບ‫ث‬
́ཛྷఱ̈́΋ΑΠ͂শ‫̥̥̦ͤۼ‬Ȃ‫ٳ‬อષ͈ၙ௸౲‫̽̈́͂ٴ‬
̞͈̦࡛̀ͥે̳́ȃ
জ̹̻͈ࡄ‫ݪ‬৒͉́ȂུίυΓᾺ̤̞ͅඅͅఉఱ̈́শ
‫ۼ‬ȂႻႁȂ΋ΑΠͬါ̳ͥ൲໤৘ࡑͬȂŪőŔ ဇြ໦‫ا‬ळ
༾̥ͣैୋ̱̹ழ૕ఘ́యఢ̳̭ͥ͂ͬ࿒എ̱͂̀ࡄ‫ݪ‬
ͬই̱̹͛͘ȃߓఘഎ͉ͅȂ‫ڐ‬ಫ߿૤޼છ͈̈́̓֒ഥഎ
ள֦ͬခ̳ͥ੏۪‫ܕ‬৖ۛͬΗȜΊΛΠ̱͂Ȃ
Ȫˍȫ࠲ુ৪
̤͍ۛ͢৪̥ͣ ŪőŔ ळ༾ͬैୋȂ
Ȫˎȫ૤޼ळ༾͒໦‫ا‬ည
൵Ȃ
Ȫˏȫࢥ‫ڠ‬എ਀༹ͬဥ̞ Ĵ ষࡓ͈ழ૕ఘͬैୋȂ
Ȫːȫ
‫ࣣا‬໤ρͼήρςȜ̥ͣ࢓༞࿪सഞ‫ح‬Ȃ
Ȫˑȫ૤޼အழ૕
ఘ͈࿪सͅచ̳ͥ؊൞ບ‫ͬث‬ঔ࣐̳ͥထ೰̳́ȃུࡄ‫ݪ‬
ͤ͢ͅ૧̹̈́࿪໤ບ‫ࠏث‬ΏΑΞθ͈ࢹಃ̦ࢹಃ̯ͦͦ͊Ȃ
஻࿪ίυΓΑ͈ࠠഎ̈́࢘ၚ‫̩̥ࣺ̈́́ͤ͊ͥ͛ࡉ̦ا‬Ȃ
࿪स͈ͤ͢ႉ઄ͅ߃̞࿪໤൲ఠͬບ‫ܢ̧̦̭͂ͥ́ث‬ఞ
̯̳ͦ͘ȃ̯ͣͅ൲໤৘ࡑၾ͈ఱ໙̈́ॉࡘ̦‫خ‬ෝ͂̈́ͤȂ
ႃၑഎ͜ͅབ̱̞͂͘ࣉ̢̤̳̀ͤ͘ȃ
ུίυΐͿ·Π͉໹଼ ijĶ ාഽͤ͢‫ٳ‬ই̱Ȃႉ઄؊ဥͬ
ુͅැ൮ͅ౾̞̀ࡄ‫ͤ৾ͅݪ‬ழ̞̳ͭ́͘ȃ
଎ġŪőŔ ဇြ૤޼ळ༾ȃζ;Α ŪőŔ ळ༾̥ͣ૤޼ळ༾ͅ໦
‫ا‬ည൵̱Ȃ྾‫ע‬அ૗Ȫષ଎ȫ̤͍͢ œŕĮőńœ ༹́ບ‫̱ث‬
̹̭͂ͧȂ૤޼අ։എഢৢ֦ঊ̜́ͥ ňłŕłĵ ̤͍͢
ŏŬŹijįĶȂਓੀ‫۾‬ႲΗϋΩ·̜́ͥϷĮŢŤŵŪůŪůȂťŦŴŮŪů ൝
͈อ࡛ͬ෇̹͛ȃ̹͘ ŪőŔ ळ༾ैୋͅष̱൵ව̱̹֒ഥ
ঊȪŐŤŵĵĭġŔŰŹijĭġŤĮŎźŤĭġŌŭŧĵȫ͈ อ ࡛ ͉ ෇ ͛ ̈́ ̥ ̽ ̹
ȃ
ȪŚŶġŕįġńŪųŤġŋġijıIJĴĭġŎŪŬŪġŌįġŔŵŦŮġńŦŭŭŴġŕųŢůŴŭġŎŦťġijıIJijȫ
஻࿪‫ܖ‬๕ܿ੅‫ٳ‬อξΣΛΠ
ŪőŔ ळ༾൲ఠίυΐͿ·Π
iPS Cell-based Projects on Cell
Transplantation and Cell Dynamics
特任教授(常勤) 大橋 一夫 Specifically Appointed Professor Kazuo OHASHI
06-6879-4091
[email protected]
Hiroyuki TSUCHIYA
(兼任)
教 授 大橋 一夫
ȁळ༾̥ͣ௫‫ͬܕ‬஻ͥȂ̷͉ͦȂ֓࿪‫ڠ‬ႀ֖͈́‫͈ޭݪ‬
‫ه‬ఴ̜́ͤȂυζϋ̜͏ͦͥΞȜζ̳́ȃ̶̈́Ȃ۴௫͉
ಸ‫ࠬۯ‬ၠȪ࿝ྤȫ͂ఱ੏۪͈‫ͅۼ‬պ౾̱̞͈̥̀ͥȂ̷
͈ຈட଻͉̭̜͈̥̓ͥͅȃ۴௫̞̠͂௫‫ͬܕ‬႕̜̬ͅ
ͥ͂Ȃ۴௫͉ષໜ໐ͅంह̳ͥఱ̧̈́ˍ͈̾௫‫̠̞͂ܕ‬
‫ٽ‬ැ͈͂͜ͅࡄ‫͞ݪ‬হၷ‫ٳ‬อ̦̳̳̞̳̦͛ͣͦ̀͘Ȃ
୆ఘ͈͂‫ܥ‬ෝ‫۾‬Ⴒ͞ఈ௫‫͈͂ܕ‬Ⴒࠈͬࣉ̢ͥ͂Ȃ̽͂͜
ুဇ̈́ࠁఠ͈۴௫Ȇळ༾̦୆ఘͅంह̱̞̞͈̥̀͜͜
౶̵ͦͭ͘ȃ
ȁུίυΐͿ·Π͉́Ȃ௫‫͞ܕ‬ळ༾̧͉̭̠̜͓̞ͥ͂
̠ਲြ͈‫ٽ‬ැ̴͂ͣͩͦͅȂুဇ̈́อே́Ȃळ༾͂ࢊͤ
ࣣ̞̦̈́ͣȂ୆ఘඤ̤̞̀ͅచયळ༾̦‫ܥ‬ෝ̞̥ͬͭ̈́
̩อ‫ͬ੅̳ͥܞ‬ౝ̧̱̞̳॑̀͘ȃळ༾̦య৫͞౩ฒॲ
୆̢࣐ͬ͊হၷͬ࿒എ̱̹͂ழ૕ैୋ̳͂̈́ͤ͘ȃ̦ͭ
ळ༾͈୆಍‫̦֚̾ࢹܥ‬ٜྶ̧́ͦ͊Ȃ̷͈ၔ༐̱̦ࢯ̦
ͭহၷ̧͍̳ࠫ̾͘ͅȃ৘ࡑ൲໤͈୆ఘඤ́చયळ༾͈
୆಍̦ଷࢄ̧́ͦ͊Ȃ̷͈ͦͣळ༾ͬခ̳ͥ൲໤͉Ȃ̭
̞̹̩ͦ́̈́̽͘͘ͅ૧̱̞࿪࢘Ȇඉ଻ບ‫ܥ͈ث‬ٛͬ೹
‫̳̩̱ͦ̀͘ރ‬ȃ
⓶ୗ䛷⏕╔⤌⧊໬䛧䛯䜲䞁䝇䝸䞁
⏘⏕⣽⬊⩌
ᴟ⣽䝣䜯䜲䝞䞊ෆ඘ሸ䛷㧗ᶵ⬟
䜢Ⓨ᥹䛩䜛⫢⣽⬊䛸ᨭᣢ⣽⬊
ϱϬPŵ
ϭϬϬPŵ
ࡄ‫هݪ‬ఴ
1)iPS 細胞分化過程と組織工学を融合した新規創薬基盤の開発
2)肝・膵・腎組織工学と遺伝子治療による新規治療法の開発
3)細胞膜と血液特性の関連を軸とした癌転移過程の解明
4)健康促進にむけた味覚・嗅覚再生の探索研究
ड߃͈৽ါა໲
1. Yamada M, Utoh R, Ohashi K, Tatsumi K, Yamato M, Okano T, Seki M. Controlled formation of heterotypic hepatic micro-organoids in anisotropic
hydrogel microfibers for long-term preservation of liver-specific functions. Biomaterials, 33: 8304-8315, 2012.
2. 大橋一夫 再生医療叢書 第5巻 肝細胞移植と肝組織工学「代謝系臓器の再生医療」 後藤満一、大橋一夫:編 朝倉書店 pp123-132, 2012.
3. Takayama K, Kawabata K, Inamura M, Ohashi K, Nagamoto Y, Okuno H, Yamaguchi Y, Tashiro K, Sakurai F, Hayakawa T, Kusuda-MF, Muzuguchi
+&&$$7HQKDQFHUELQGLQJSURWHLQPHGLDWHGUHJXODWLRQRI7*)ȕUHFHSWRUH[SUHVVLRQGHWHUPLQHVKHSDWREODVWIDWHGHFLVLRQ'HYHORSPHQW
91-100, 2014.
4. Ohashi K, Okano T. Functional tissue engineering of the liver and islets. Anatomical Record, 297: 73-82, 2014.
஻࿪ႉ઄ࡄ‫ݪ‬ଔૺξΣΛΠ
‫֓ॸړ‬࿪஻଼ίυΐͿ·Π
Clinical Drug Development Unit
Drug Discovery Sciences for Oligonucleotide Therapeutics
教 授
小比賀 聡 Professor
特任助教(常勤) 藤坂 朱紀 Specially Appointed Assistant Professor
助 教(兼任) 山本 剛史 Assistant Professor
Satoshi OBIKA
06-6879-8200
Aki FUJISAKA
06-6879-8202
Tsuyoshi YAMAMOTO 06-6879-8202
[email protected]
[email protected]
[email protected]
̳ȃ̹͘Ȃࣞ‫ܥ‬ෝ଻‫ॸړ‬໦ঊͬဥ̞̹ດഎழ૕͈͒࢘ၚ
എ௣ో͈ࡄ‫ͬݪ‬ଔૺ̱Ȃ஻࿪‫ܖ‬๕ܿ੅ႁ͈ူ଼͞ࡄ‫ݪ‬৪
଼͈֗৾ͤͅழ̞̳ͭ́͘ȃ
ȁ֓࿪຦͈‫ٳ‬อ͉́Ȃȶ̩̳ͤȷ͈ਅͬౝ̳ࡄ‫̥ͣݪ‬ই
ͤ͘Ȃ଼ࣣࡄ‫ݪ‬ȂΑ·ςȜΣϋΈ͂࡞ͩͦͥ෽ူळ༾͞
൲໤ͬဥ̞̹࿪͈࢘̈́̓ບ‫̦ͤ߫ث‬༐̱࣐ͩͦȂచય͂
̳ͥ৖͈ۛহၷͅडഐ͈‫ࣣا‬໤ͬࣆ̧ࣺ̞̳ͤͭ́͘ȃ
̭͈̠֚̈́͢Ⴒ͈ౝ॑എࡄ‫࢓̱̀͂ض͈ࠫݪ‬༞໤ৗ̦ࡉ
̞̺̯ͦͥ͂Ȃষ͈౲‫࢓̱̀͂ٴ‬༞໤ৗ͈ୋ௮࠿൦͞຦
ৗບ‫ث‬Ȃհ஠଻ບ‫̓̈́ث‬Ȃႉ઄দࡑ̫̹࢜ͅ࠿൦̦̤̭
̳̈́ͩͦ͘ȃ
ȁŅŏł ͞ œŏł ͅैဥ̳ͥȶ࿪सȷͅȂ‫֓ॸړ‬࿪̦̜
̳ͤ͘ȃ̭͈‫֓ॸړ‬࿪̤̫ͥͅ஻࿪ࡄ‫́͜ݪ‬൳အً͈೾
ͬࠐ̞̳̀͘ȃ༷֚́Ȃ‫ॸړ‬໦ঊ̦ਲြ͈֓࿪຦ͅ๤͓
໦ঊၾ̦ఱ̧̞̭͂͞ഩ‫ͬك‬ఝ̷͍̞̭͈̀ͥ͂̈́̓໦
ঊഎ଻ৗ͈̹͛Ȃ‫֓ॸړ‬࿪͈஻࿪͉́Ȃດഎழ૕͈͒௣
ో̦̱̱͊͊‫ه‬ఴ̳͂̈́ͤ͘ȃ̭͈အ̈́‫ه‬ఴͬ࣪໚̱Ȃ
ͤ࢘͢‫ض‬എ̈́࿪࢘ͬࡉ̞̺̳̹͛ͅȂ‫֓ॸړ‬࿪ͬດഎழ
૕͒࢘ၚഎͅ௣ో̵̯ͥࡄ‫̳̞࣐̦̀ͦͩ͘ݪ‬ȃ
ȁ̭̠̞̹࡛̽ેͬ൩ِ̢̀͘ș͉Ȃࣞ΋τΑΞυȜσ
ࠬછ൝ͬΗȜΊΛΠ৖̱̹ۛ͂ͺϋΙΓϋΑ‫֓ॸړ‬࿪͈
ႉ઄দࡑ̫̹࢜ͅ஻࿪ࡄ‫ͬݪ‬Ȃ‫ڠ‬ඤ͞‫͂۾ܥݪࡄ͈ٸڠ‬
͈‫ވ‬൳ࡄ‫ݪ‬Ȃ໼͍ͅ൳̲ξΣΛΠ͈‫֓ॸړ‬࿪ບ‫ڠشث‬
őŋ ͞‫֓ॸړ‬࿪ႉ઄࿪ম őŋ ͈͂Ⴒࠈͤ͢ͅ৘ঔ̱̞̀͘
ற෷ୢఇ൉ਛ
'1$
৴௚
51$
ற෷ୢఇ௬੼ఐ৾
ఏ৓఩஫৕भੰෲ
ற෷ୢఇभ়ਛଢ଼஢
যੵற෷॑৷ःञ
൉ఇଢ଼஢
৴௚
ৰୡ৿੟पेॊ
ఇ஍भ௬੼
ॹ‫ॱش‬ঋ‫ش‬५ಉ॑
ણ৷खञੰෲ
သു಍ཝ॑ઞढञ
ఇ஍௬੼
৴௚
ற෷ୢఇಏ෫ఇহ
ࡄ‫هݪ‬ఴ
1)高コレステロール血症をターゲットとしたアンチセンス医
薬の創成研究
2)核酸医薬の標的組織への効率的送達に関する研究